-
1.Substituted melatonin derivatives, process for their preparation, and methods of use 失效
标题翻译: 取代的褪黑激素衍生物,其制备方法和使用方法公开(公告)号:US20070191463A1
公开(公告)日:2007-08-16
申请号:US10583804
申请日:2004-12-23
申请人: Chunlin Tao , Cheng-Zhi Yu , Neil Desai , Vuong Trieu
发明人: Chunlin Tao , Cheng-Zhi Yu , Neil Desai , Vuong Trieu
IPC分类号: A61K31/405 , C07D209/36 , C07D209/18
CPC分类号: C07D209/16 , C07D209/14 , C07D403/04 , C07D405/04 , C07D409/04
摘要: The invention provides 2 aryl substituted derivatives of melatonin. The invention further provides pharmaceutical compositions comprising such derivatives, methods for preparing such derivatives, and methods of using such derivatives to induce general anesthesia, sedation, and/or hypnotic or sleep effects in a patient, and to treat conditions affected by melatonin activity in a patient.
摘要翻译: 本发明提供了2种褪黑激素的芳基取代衍生物。 本发明还提供了包含这种衍生物的药物组合物,制备这些衍生物的方法,以及使用这些衍生物诱导患者全身麻醉,镇静和/或催眠或睡眠作用的方法,以及治疗受褪黑素活性影响的病症 患者。
-
公开(公告)号:US20100279963A1
公开(公告)日:2010-11-04
申请号:US12829081
申请日:2010-07-01
申请人: Chunlin Tao , Qinwei Wang , Vuong Trieu , Neil Desai , Patrick Soon-Shiong
发明人: Chunlin Tao , Qinwei Wang , Vuong Trieu , Neil Desai , Patrick Soon-Shiong
IPC分类号: A61K31/165 , A61K31/122 , A61K31/132 , A61K31/353 , A61K31/336 , A61K31/341 , A61K31/121 , A61K31/12 , A61K31/36 , A61K31/4409 , A61K31/495 , A61K31/496 , A61K31/40 , A61K31/337 , A61K31/704 , A61K31/513 , A61P35/00
CPC分类号: C07C69/738 , C07C49/203 , C07C49/217 , C07C49/223 , C07C49/235 , C07C49/255 , C07C49/553 , C07C49/613 , C07C49/657 , C07C49/67 , C07C49/683 , C07C49/697 , C07C49/747 , C07C49/753 , C07C49/755 , C07C49/784 , C07C59/84 , C07C59/90 , C07C225/22 , C07C233/15 , C07C235/78 , C07C251/40 , C07C251/44 , C07C2601/16 , C07D209/34 , C07D213/74 , C07D261/18 , C07D295/185 , C07D307/33 , C07D311/22 , C07D317/54
摘要: Derivatives of dicarbonyl compounds having antitumor and antibiotic activity which can be used as anticancer agents.
摘要翻译: 可用作抗癌剂的具有抗肿瘤和抗生素活性的二羰基化合物的衍生物。
-
公开(公告)号:US07799954B2
公开(公告)日:2010-09-21
申请号:US11939909
申请日:2007-11-14
申请人: Chunlin Tao , Qinwei Wang , Vuong Trieu , Neil Desai , Patrick Soon-Shiong
发明人: Chunlin Tao , Qinwei Wang , Vuong Trieu , Neil Desai , Patrick Soon-Shiong
CPC分类号: C07C69/738 , C07C49/203 , C07C49/217 , C07C49/223 , C07C49/235 , C07C49/255 , C07C49/553 , C07C49/613 , C07C49/657 , C07C49/67 , C07C49/683 , C07C49/697 , C07C49/747 , C07C49/753 , C07C49/755 , C07C49/784 , C07C59/84 , C07C59/90 , C07C225/22 , C07C233/15 , C07C235/78 , C07C251/40 , C07C251/44 , C07C2601/16 , C07D209/34 , C07D213/74 , C07D261/18 , C07D295/185 , C07D307/33 , C07D311/22 , C07D317/54
摘要: Derivatives of dicarbonyl compounds having antitumor and antibiotic activity which can be used as anticancer agents.
摘要翻译: 可用作抗癌剂的具有抗肿瘤和抗生素活性的二羰基化合物的衍生物。
-
4.
公开(公告)号:US20070185217A1
公开(公告)日:2007-08-09
申请号:US10584017
申请日:2004-12-23
申请人: Chunlin Tao , Cheng Yu , Neil Desai , Vuong Trieu
发明人: Chunlin Tao , Cheng Yu , Neil Desai , Vuong Trieu
IPC分类号: A61K31/05
CPC分类号: C07C205/45 , A61K31/05 , A61K31/095 , A61K31/12 , A61K31/15 , C07C39/367 , C07C39/373 , C07C45/46 , C07C49/83 , C07C49/84 , C07C69/78 , C07C225/22 , C07C235/84 , C07C251/48 , C07C255/56 , C07C309/87 , C07C311/29 , C07C317/24 , C07C325/02 , C07D317/54 , C07D317/56 , C07D317/58
摘要: The invention provides para substituted dialkylphenol derivatives of propofol. The invention further provides pharmaceutical compositions comprising such analogs, methods for preparing such analogs, and methods of using such analogs to induce general anesthesia, sedation, and/or hypnotic or sleep effects in a patient.
摘要翻译: 本发明提供异丙酚的对位取代的二烷基酚衍生物。 本发明进一步提供包含此类类似物的药物组合物,制备此类类似物的方法,以及使用此类类似物诱发患者全身麻醉,镇静和/或催眠或睡眠效应的方法。
-
公开(公告)号:US20080146586A1
公开(公告)日:2008-06-19
申请号:US11939909
申请日:2007-11-14
申请人: Chunlin Tao , Qinwei Wang , Vuong Trieu , Neil Desai , Patrick Soon-Shiong
发明人: Chunlin Tao , Qinwei Wang , Vuong Trieu , Neil Desai , Patrick Soon-Shiong
IPC分类号: A61K31/496 , C07C49/00 , A61K31/12 , C07C49/223 , C07C233/11 , A61P35/00 , A61K31/165 , C07D241/04 , A61K31/495 , C07D401/04
CPC分类号: C07C69/738 , C07C49/203 , C07C49/217 , C07C49/223 , C07C49/235 , C07C49/255 , C07C49/553 , C07C49/613 , C07C49/657 , C07C49/67 , C07C49/683 , C07C49/697 , C07C49/747 , C07C49/753 , C07C49/755 , C07C49/784 , C07C59/84 , C07C59/90 , C07C225/22 , C07C233/15 , C07C235/78 , C07C251/40 , C07C251/44 , C07C2601/16 , C07D209/34 , C07D213/74 , C07D261/18 , C07D295/185 , C07D307/33 , C07D311/22 , C07D317/54
摘要: Derivatives of dicarbonyl compounds having antitumor and antibiotic activity which can be used as anticancer agents.
摘要翻译: 可用作抗癌剂的具有抗肿瘤和抗生素活性的二羰基化合物的衍生物。
-
6.Use of 2 anti-SPARC antibodies to predict response to melanoma chemotherapy 有权
标题翻译: 使用2种抗SPARC抗体来预测黑素瘤化疗的反应公开(公告)号:US08383358B2
公开(公告)日:2013-02-26
申请号:US12790231
申请日:2010-05-28
申请人: Vuong Trieu , Neil Desai , Daniel Knauer
发明人: Vuong Trieu , Neil Desai , Daniel Knauer
IPC分类号: G01N33/574 , C07K16/00 , C12P21/08 , A61K39/395 , A61P35/00
CPC分类号: G01N33/6893 , A61K38/38 , A61K47/48284 , A61K47/48884 , A61K47/643 , A61K47/6929 , G01N33/57484 , G01N2800/52 , A61K2300/00
摘要: The invention provides anti-SPARC antibody-based techniques for predicting a response to chemotherapy.
摘要翻译: 本发明提供了用于预测化疗反应的基于抗SPARC抗体的技术。
-
公开(公告)号:US20050004002A1
公开(公告)日:2005-01-06
申请号:US10731224
申请日:2003-12-09
申请人: Neil Desai , Andrew Yang , Tapas De , Sherry Ci , Patrick Soon-Shiong , Vuong Trieu , Oiang Yao , Bridget Grim
发明人: Neil Desai , Andrew Yang , Tapas De , Sherry Ci , Patrick Soon-Shiong , Vuong Trieu , Oiang Yao , Bridget Grim
IPC分类号: A61K9/00 , A61K9/19 , A61K31/00 , A61K47/18 , A61K47/48 , A61K38/13 , A61K38/17 , A61K31/704 , A61K31/337 , A61K31/56 , A61K31/4745
CPC分类号: A61K47/42 , A61K9/0019 , A61K9/0078 , A61K9/107 , A61K9/1075 , A61K9/146 , A61K9/19 , A61K31/00 , A61K31/05 , A61K31/16 , A61K31/164 , A61K31/165 , A61K31/198 , A61K31/24 , A61K31/337 , A61K31/343 , A61K31/355 , A61K31/427 , A61K31/436 , A61K31/4745 , A61K31/7048 , A61K38/13 , A61K47/18 , B82Y5/00 , Y10S977/705 , Y10S977/773 , Y10S977/779 , Y10S977/906 , Y10S977/911 , A61K2300/00
摘要: The present invention relates to a pharmaceutical composition comprising a pharmaceutical agent and a pharmaceutically acceptable carrier, which carrier comprises a protein, for example, human serum albumin and/or deferoxamine. The human serum albumin is present in an amount effective to reduce one or more side effects associated with administration of the pharmaceutical composition. The invention also provides methods for reducing one or more side effects of administration of the pharmaceutical composition, methods for inhibiting microbial growth and oxidation in the pharmaceutical composition, and methods for enhancing transport and binding of a pharmaceutical agent to a cell.
摘要翻译: 本发明涉及包含药剂和药学上可接受的载体的药物组合物,该载体包含蛋白质,例如人血清白蛋白和/或去铁胺。 人血清白蛋白以有效降低与药物组合物施用相关的一种或多种副作用的量存在。 本发明还提供了用于减少药物组合物施用的一种或多种副作用的方法,用于抑制药物组合物中的微生物生长和氧化的方法,以及用于增强药剂与细胞的转运和结合的方法。
-
8.SPARC MICROENVIRONMENT SIGNATURE, PLASMA SPARC, AND LDH AS PROGNOSTIC BIOMARKERS IN THE TREATMENT OF CANCER 审中-公开
标题翻译: SPARC微环境标志,PLASMA SPARC和LDH作为预防癌症的预防生物标志物公开(公告)号:US20130281376A1
公开(公告)日:2013-10-24
申请号:US13878067
申请日:2011-10-07
申请人: Vuong Trieu , Larn Hwang , Kouros Motamed , Xiping Liu , Neil Desai
发明人: Vuong Trieu , Larn Hwang , Kouros Motamed , Xiping Liu , Neil Desai
IPC分类号: G01N33/68
CPC分类号: G01N33/6893 , G01N33/57484 , G01N2800/52
摘要: The invention provides multiparametric anti-SPARC antibody-based techniques for treating cancers as well as determining prognosis and predicting the response to therapy, including chemotherapy, radiotherapy, surgical therapy and combination therapies.
摘要翻译: 本发明提供了用于治疗癌症的多参数抗SPARC抗体技术,以及确定预后并预测对治疗的反应,包括化疗,放疗,手术治疗和联合疗法。
-
公开(公告)号:US20120087910A1
公开(公告)日:2012-04-12
申请号:US13256135
申请日:2010-03-11
申请人: Vuong Trieu , Daniel Knauer , Neil Desai
发明人: Vuong Trieu , Daniel Knauer , Neil Desai
IPC分类号: A61K38/17 , C12N15/12 , A61P9/00 , C12N15/63 , A61P35/00 , A61K39/395 , C12N1/21 , C12N1/19 , C12N5/10 , A61N5/00 , A61P35/02 , C07K14/47 , C12Q1/02
CPC分类号: C07K14/47 , A61K38/00 , A61K38/1709 , A61K45/06 , C07K14/4748
摘要: The invention provides compositions and methods which exploit the discovery of the SPARC carboxy angiogenic domain.
摘要翻译: 本发明提供利用发现SPARC羧基血管生成结构域的组合物和方法。
-
10.TREATMENT, DIAGNOSTIC, AND METHOD FOR DISCOVERING ANTAGONIST USING SPARC SPECIFIC MIRNAS 审中-公开
标题翻译: 治疗,诊断和使用SPARC特异性MIRNAS发现ANTAGONIST的方法公开(公告)号:US20090220589A1
公开(公告)日:2009-09-03
申请号:US12395872
申请日:2009-03-02
申请人: Vuong Trieu , Larn Hwang , Neil Desai
发明人: Vuong Trieu , Larn Hwang , Neil Desai
CPC分类号: A61K31/7088 , A61K31/7105 , C12N15/113 , C12N2310/111 , C12N2310/141 , C12N2330/10
摘要: miRNAs that regulate human SPARC and methods of use thereof are described. Suitable nucleic acids for use in the methods and compositions described herein include, but are not limited to, pri-miRNA, pre-miRNA, ds miRNA, mature miRNA or fragments of variants thereof that retain the biological activity of the mature miRNA and DNA encoding a pri-miRNA, pre-miRNA, mature miRNA, fragments or variants thereof, or regulatory elements of the miRNA.
摘要翻译: 描述了调节人类SPARC的miRNA及其使用方法。 用于本文所述方法和组合物的合适的核酸包括但不限于保留生物学miRNA和编码DNA的生物活性的pri-miRNA,pre-miRNA,ds miRNA,成熟miRNA或其变体片段 pri-miRNA,前miRNA,成熟miRNA,其片段或变体或miRNA的调节元件。
-
-
-
-
-
-
-
-
-